#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Krabbe's disease NTRK gene fusion overexpression Ventricular tachycardia Osteomyelitis Human papilloma virus immunisation Deafness Anal cancer SAPHO syndrome Granulomatosis with polyangiitis Acute graft versus host disease Idiopathic pulmonary fibrosis Acquired haemophilia Glomerulonephritis minimal lesion Thyroid cancer metastatic Gastrointestinal neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets Haemophilia B without inhibitors Cholangitis sclerosing – Trials in Disease Antithrombin III deficiency Congenital generalised lipodystrophy – Diagnostics Fabry’s disease – Basic Information Pulmonary sarcoidosis Basal cell naevus syndrome – Diagnostics Lysosomal storage disorder – Life with Disease Erdheim-Chester disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gadoteric Acid Izokibep Utreloxastat Mps-200 Nimodipine TRIACYLGLYCEROL LIPASE Dupilumab Indometacin Ph. Eur. Mycophenolate Mofetil Bp1.7881A Prs-344 VALACICLOVIR HYDROCHLORIDE Ziprasidone Oxybutynin Opium, Standardized Powdered Milademetan [18F]-Altanserin Benztropine Mesylate Golcadomide Ertapenem More therapies…

    Learn about Your Condition

    Antisynthetase syndrome Rabies Insomnia Vulvar dysplasia Nasal sinus cancer Pelizaeus-Merzbacher disease Lymphangioleiomyomatosis Leukocyte adhesion deficiency Haemorrhage prophylaxis Intracranial calcification Sjogren's syndrome Metastases to lymph nodes Colon cancer stage II Ligament sprain Vertigo More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pyelonephritis acute

  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ciprofloxacin
    Belgium

  • Study on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Meropenem
    • Vaborbactam
    Czechia France Italy Poland Spain

  • Study on 7-Day vs. 14-Day Antibiotic Treatment for Kidney Infection in Transplant Patients Using Bromhexine Hydrochloride, Trimethoprim, and Fluoroquinolones

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    • Pyelonephritis
    • Renal transplant
    Investigated Drugs:
    • Tolu Balsam
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    France

  • Study on Antibiotic Treatments for Kidney Infection in Children: Comparing Cefixime, Ceftriaxone, and Amikacin for Ages 1 Month to 3 Years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Cefixime Trihydrate
    • Amikacin Sulfate
    • Tolu Balsam
    France

  • Study on Cefepime and Enmetazobactam for Children with Complicated Urinary Tract Infections, Including Acute Pyelonephritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    Investigated Drugs:
    • Enmetazobactam
    • Cefepime
    Czechia France Hungary Poland Slovakia Spain

  • Study of meropenem-vaborbactam safety and effectiveness in children aged 3 months to 12 years with complicated urinary tract infection or acute pyelonephritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pyelonephritis acute
    • Urinary tract infection
    Investigated Drugs:
    • Meropenem
    • Vaborbactam
    Belgium Bulgaria Croatia Greece Poland Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!